Evidence map›Paper›PMID 41696140›Full record

ReviewBiomedical reports2026

Pharmacological properties of the ethnomedicinal plant

Aaliyah Saferdien, Babalwa Yekelo, Shaheen Mowla

Abstract readReview
In one paragraph

Review in Biomedical reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Aaliyah SaferdienDepartment of Pathology, Division of Haematology, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa.
Babalwa YekeloDepartment of Pathology, Division of Haematology, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa.
Shaheen MowlaDepartment of Pathology, Division of Haematology, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Continuous and rigorous assessment of the pharmacological potential of plants is essential for the discovery and development of novel anticancer and other therapeutic agents. Ongoing evaluation also ensures validation of traditional uses while optimizing efficacy and safety. The reporting of these evaluations serves to support innovation of the pharmaceutical landscape to advance evidence-based medicine. Such is particularly important for research in cancer, a highly complex disease that remains a leading cause of mortality worldwide. Numerous conventional anticancer drugs are derived from natural products, highlighting the value of plants as a source of novel compounds with anticancer properties. The medicinal plant,

Indexed as

anticancer activityDodonaea viscosamedicinal plantsnatural products

Identifiers

PMID41696140
PMCPMC12902742

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.